Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Vasanthi Balaraman"'
Autor:
Ambreen Azhar, Makoto Tsujita, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, James D. Eason, Simonne S. Nouer, Keiichi Sumida, Adam Remport, Isaac E. Hall, Randi Griffin, George Rofaiel, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 831-841 (2022)
Kidney transplants (KT) from hepatitis C (HCV) viremic donors to HCV negative recipients has shown promising renal outcomes, however, high incidence of cytomegalovirus (CMV) viremia were reported. We performed a prospective cohort study of 52 HCV neg
Externí odkaz:
https://doaj.org/article/cdcf3979863f4aa7a21b8c2cbaa2a9c5
Autor:
Jiten P. Kothadia, MD, Anshul Bhalla, MD, Miklos Z. Molnar, MD, PhD, Rahul Mohan, MD, Vasanthi Balaraman, MD, Manish Talwar, MD, Ryan Helmick, MD, Corey Eymard, MD, Ian Clark, MD, Richa Jain, MD, Thomas W. Faust, MD, MBE, Jason M. Vanatta, MD, James D. Eason, MD, Satheesh P. Nair, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 6, p e1342 (2022)
Background. Long-term liver outcome in hepatitis C virus (HCV)-negative kidney recipients who acquired HCV infection from viremic donors is of intense interest in the transplant community. We evaluated the incidence of fibrosis in liver biopsy specim
Externí odkaz:
https://doaj.org/article/8eb7e105f346446aa61a464ecf9d255a
Autor:
Masahiko Yazawa, Orsolya Cseprekal, Ryan A. Helmick, Manish Talwar, Vasanthi Balaraman, Pradeep S. B. Podila, Sallyanne Fossey, Sanjaya K. Satapathy, James D. Eason, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 40-47 (2020)
Background De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be a
Externí odkaz:
https://doaj.org/article/e8b9fb1de5794ea7a7d9318f5bec14c1
Autor:
Uchenna Agbim, Orsolya Cseprekal, Masahiko Yazawa, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, Pradeep S. B. Podila, Benedict Maliakkal, Satheesh Nair, James D. Eason, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 767-775 (2020)
Background We aimed to assess the probability and factors associated with the presence of hepatitis C virus (HCV) antibody among HCV seronegative kidney transplant recipients receiving HCV-infected (nucleic acid testing positive) donor kidneys. Metho
Externí odkaz:
https://doaj.org/article/ed50f412bcfb4593a387fb25c3f52342
Autor:
Masahiko Yazawa, Tibor Fülöp, Orsolya Cseprekal, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, Ambreen Azhar, Csaba P. Kovesdy, James D. Eason, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 1083-1092 (2020)
Background Deceased-donor kidney transplantation (KT) from hepatitis C (HCV)-infected donors into HCV-uninfected recipients (HCV D+/R−) could become standard care in the near future. However, HCV viral replication by viral transmission might lead t
Externí odkaz:
https://doaj.org/article/edcdb67fa5b34ab0b3abfed2316485b7
Autor:
Ambreen Azhar, Anshul Bhalla, Rachel C. Forbes, Beatrice P. Concepcion, Roy D. Bloom, Deirdre Sawinski, Miklos Z Molnar, Jennifer Trofe-Clark, Raymond T. Chung, Peter P. Reese, Vasanthi Balaraman, David Shaffer, Ian A. Strohbehn, Behdad Besharatian, Douglas E. Schaubel, Emily A. Blumberg, Mital Shah, David S. Goldberg, Manish Talwar, Laura A Binari, Nahel Elias, James D. Eason, Vishnu S. Potluri, Meghan E. Sise
Publikováno v:
Am J Transplant
Kidney transplantation (KT) from deceased donors with hepatitis C virus (HCV) into HCV-negative recipients has become more common. However, the risk of complications such as BK polyomavirus (BKPyV) remains unknown. We assembled a retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b3fe99e014e2e1f6466181df9bfec2
https://doi.org/10.1111/ajt.16834
https://doi.org/10.1111/ajt.16834
Autor:
Miklos Z. Molnar, Anshul Bhalla, Vasanthi Balaraman, Praveen K. Potukuchi, Csaba P. Kovesdy, Manish Talwar, Ambreen Azhar, Makoto Tsujita, James D. Eason, Masahiko Yazawa
Publikováno v:
Transplant International. 33:1732-1744
The kidney donor profile index (KDPI) defines an hepatitis C (HCV) positive donor based on HCV antibody (Ab) and/or nucleic acid amplification test (NAT) positivity, with donors who are not actively infected (Ab+/NAT-) also classified as HCV positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccb89928a60c00cbfbc2f44c2a9ba30
https://doi.org/10.1111/tri.13743
https://doi.org/10.1111/tri.13743
Autor:
Masahiko Yazawa, James D. Eason, Orsolya Cseprekál, Vasanthi Balaraman, Ambreen Azhar, Anshul Bhalla, Pradeep S. B. Podila, Miklos Z. Molnar, L. Nicholas Cossey, Manish Talwar
Publikováno v:
Kidney International Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e53edfa878582ee80e57bdf0154f5d
https://doi.org/10.1016/j.ekir.2020.03.026
https://doi.org/10.1016/j.ekir.2020.03.026
Autor:
Sanjaya K. Satapathy, Vasanthi Balaraman, Ryan A. Helmick, James D. Eason, Sallyanne Fossey, Manish Talwar, Masahiko Yazawa, Pradeep S. B. Podila, Orsolya Cseprekal, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 40-47 (2020)
Renal Failure
Renal Failure
Background: De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec79e80f795d3d9a9fa142518c07752a
https://doaj.org/article/e8b9fb1de5794ea7a7d9318f5bec14c1
https://doaj.org/article/e8b9fb1de5794ea7a7d9318f5bec14c1
Autor:
Manish Talwar, James D. Eason, Masahiko Yazawa, Pradeep S. B. Podila, Uchenna Agbim, Benedict Maliakkal, Satheesh Nair, Anshul Bhalla, Vasanthi Balaraman, Miklos Z. Molnar, Orsolya Cseprekal
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 767-775 (2020)
Renal Failure
article-version (VoR) Version of Record
Renal Failure
article-version (VoR) Version of Record
Background We aimed to assess the probability and factors associated with the presence of hepatitis C virus (HCV) antibody among HCV seronegative kidney transplant recipients receiving HCV-infected (nucleic acid testing positive) donor kidneys. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646b0740ab3c7af5bb1112876dea63be
https://doaj.org/article/ed50f412bcfb4593a387fb25c3f52342
https://doaj.org/article/ed50f412bcfb4593a387fb25c3f52342